Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

survival

Outcome Time Frame:

more than a year

Safety Issue:

Yes

Authority:

United States: Food and Drug Administration

Study ID:

12555

NCT ID:

NCT00589706

Start Date:

January 1985

Completion Date:

December 2012

Related Keywords:

• Gliomas
• high grade gliomas of the brain
• anti-body treatment
• survival
• Glioma

Name	Location
Hahneman Hospital	Philadelphia, Pennsylvania  19102